Rainbow Childrens Medicare

Rainbow Childrens Medicare

1,348.80
+31.80
(2.41%)
hide
Key Fundamentals
Add Ratio
Market Cap
13,375.30 Cr
EPS
23.97
PE Ratio
53.04
Dividend Yield
0.22 %
52 Week High
1,709.60
52 Week Low
1,218.00
PB Ratio
9.33
Debt to Equity
0.56
Sector
Hospitals
Analyst Rating and Forecast
- By Refinitiv from9 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
positive
Rainbow Children's Medicare has inaugurated a new 100-bed hospital facility in Rajahmundry, Andhra Pradesh. This represents an expansion of the company's healthcare infrastructure in the region.
neutral
Rainbow Childrens Medicare Ltd. saw a block trade executed on the NSE involving approximately 105,604 shares at a price of Rs. 1,485.00 per share, totaling Rs. 15.68 crores in transaction value.
neutral
Rainbow Children's Medicare Limited has issued a postal ballot notice seeking shareholder approval through a special resolution to provide loans up to Rs 35 crores to three companies where certain directors have interests. The borrowing companies are Rainbow Speciality Hospitals Private Limited, Prashanthi Medicare Private Limited, and Pratiksha Women & Child Care Hospital Private Limited. The first two are existing subsidiaries, while the company plans to acquire 76% equity and 100% preference shares in Pratiksha Women & Child Care Hospital. The e-voting period runs from August 29 to September 27, 2025, with results to be announced by September 30, 2025. The loans will be utilized for principal business activities of the borrowing companies.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,202.70
#1 1,14,266.90
101.89
7,184.10
#1 28.68
1,076
30.34
60.77
7,901.50
1,12,633.70
69.74
#1 21,994.30
14.76
#1 1,505
39.78
64.47
1,084.90
82,686.80
90.81
7,849.70
13.25
809
#1 53.33
68.38
1,371.70
37,523.10
69.05
3,771.40
12.59
481
49.58
53.54
702.45
36,234.80
104.27
4,286.70
15.12
337
-98.18
65.62
1,755.40
36,063.60
#1 45.68
5,575.00
12.29
790
-2.38
47.19
719.90
29,362.20
71.28
3,067.00
21.98
415
-10.71
49.37
1,348.80
#8 13,375.30
#3 53.04
#9 1,566.90
#4 17.46
#8 244
#4 35.52
41.78
1,544.00
10,034.20
52.47
1,290.20
17.77
194
-1.57
59.98
733.55
10,001.10
250.98
2,257.70
17.03
49
-55.88
71.60
Growth Rate
Revenue Growth
17.46 %
Net Income Growth
11.86 %
Cash Flow Change
23.11 %
ROE
-4.06 %
ROCE
3.26 %
EBITDA Margin (Avg.)
-1.17 %

Quarterly Financial Results

Quarterly Financials
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
166
249
271
255
219
243
321
315
326
295
341
345
354
342
429
411
385
373
Expenses
132
168
177
160
164
155
204
200
219
200
215
218
236
237
270
264
255
249
EBITDA
34
80
94
95
54
88
117
115
107
96
125
127
118
106
158
148
129
124
Operating Profit %
20 %
32 %
34 %
36 %
23 %
35 %
35 %
35 %
31 %
31 %
35 %
35 %
31 %
28 %
35 %
34 %
31 %
29 %
Depreciation
20
19
21
21
22
22
23
23
23
25
27
28
32
34
35
35
34
34
Interest
13
13
12
12
16
14
13
14
14
15
13
14
17
18
18
18
18
18
Profit Before Tax
2
48
61
62
16
52
81
78
70
56
85
85
69
53
105
94
77
71
Tax
1
12
16
17
4
13
20
20
16
14
22
22
18
14
26
25
20
18
Net Profit
1
36
45
45
12
39
62
58
54
42
63
63
51
40
79
69
57
54
EPS in ₹
0.14
3.91
4.87
4.79
1.36
3.78
6.06
5.74
5.31
4.04
6.20
6.12
5.02
3.89
7.77
6.76
5.55
5.27

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
231
349
399
448
926
1,019
1,081
1,296
1,776
2,170
2,377
Fixed Assets
78
123
174
296
702
702
772
858
931
1,253
1,398
Current Assets
98
171
125
73
133
203
197
290
484
622
822
Capital Work in Progress
35
31
7
12
23
43
29
6
23
20
29
Investments
7
2
6
0
3
10
18
22
58
308
571
Other Assets
111
194
212
140
199
265
262
409
764
590
380
Total Liabilities
231
349
399
448
926
1,019
1,081
1,296
1,776
2,170
2,377
Current Liabilities
36
42
56
71
92
130
122
125
144
150
151
Non Current Liabilities
15
13
14
15
463
480
511
564
567
756
751
Total Equity
181
295
329
362
372
409
448
606
1,065
1,265
1,475
Reserve & Surplus
166
275
309
307
317
351
392
498
958
1,157
1,367
Share Capital
15
20
20
55
55
55
55
105
102
102
102

Cash Flow

Cash Flow
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-0
-1
3
1
-2
2
2
-1
4
5
-7
10
Investing Activities
-113
-20
-107
-33
-42
-117
-117
-83
-175
-465
-227
-268
Operating Activities
15
26
17
36
48
127
170
143
224
327
321
396
Financing Activities
98
-7
93
-1
-8
-9
-52
-61
-44
143
-102
-118

Share Holding

% Holding
Dec 2021
May 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
63.70 %
49.83 %
49.83 %
49.83 %
49.83 %
49.83 %
49.83 %
49.83 %
49.83 %
49.83 %
49.88 %
49.85 %
49.85 %
49.85 %
49.85 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
21.63 %
22.32 %
24.04 %
24.78 %
25.11 %
25.12 %
23.69 %
23.59 %
DIIs
0.00 %
6.35 %
6.55 %
10.26 %
13.90 %
15.38 %
15.35 %
15.40 %
15.62 %
14.76 %
13.80 %
13.83 %
13.87 %
15.31 %
15.44 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
19.03 %
15.87 %
13.24 %
13.75 %
13.29 %
13.04 %
11.92 %
11.03 %
10.40 %
10.74 %
10.40 %
10.38 %
10.34 %
10.32 %
Others
36.30 %
24.79 %
27.75 %
26.67 %
22.52 %
21.50 %
21.78 %
1.22 %
1.21 %
0.97 %
0.80 %
0.80 %
0.77 %
0.79 %
0.79 %
No of Share Holders
146
2,43,189
1,66,064
91,530
79,224
75,611
74,690
79,187
80,471
77,152
78,557
77,524
78,764
79,092
80,320

Dividend History

Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 2 3 3 3
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.28 0.23 0.21 0.22

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
08 Sept 2022 DIVIDEND Dividend
₹ 2.00 /share
07 Sept 2022 489.05 611.60
22 Jun 2023 DIVIDEND Dividend
₹ 3.00 /share
22 Jun 2023 849.65 977.25
23 Jul 2024 DIVIDEND Dividend
₹ 3.00 /share
23 Jul 2024 1,393.75 1,145.75
30 Jul 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Jul 2024 1,393.75 1,172.30
27 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
27 Oct 2024 1,431.30 1,417.75
09 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
09 Feb 2025 1,423.75 1,383.95
24 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
24 May 2025 1,366.75 1,352.30
28 Jun 2025 DIVIDEND Dividend
₹ 3.00 /share
27 Jun 2025 1,352.30 1,512.95
05 Jul 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
05 Jul 2025 1,352.30 1,599.40
26 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
26 Jul 2025 1,526.50 1,554.50

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportSep 29, 2025
Closure of Trading WindowSep 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 13, 2025
Commencement Of A New Spoke Hospital In Rajahmundry Andhra Pradesh.Sep 10, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 29, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotAug 28, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionAug 18, 2025
Announcement under Regulation 30 (LODR)-Credit RatingAug 14, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSAug 12, 2025
Announcement under Regulation 30 (LODR)-AcquisitionAug 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 07, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 04, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 28, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 28, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJul 26, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 26, 2025
Grant Of Stock OptionsJul 26, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJul 26, 2025
Board Meeting Outcome for Board Meeting Outcome For The Board Meeting Held On July 26 2025Jul 26, 2025
Unaudited Financial Results For The Quarter Ended June 30 2025Jul 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 22, 2025
Board Meeting Intimation for Approval Of Un-Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter Ended June 30 2025.Jul 21, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 09, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportJul 07, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMJul 05, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionJul 01, 2025
Announcement under Regulation 30 (LODR)-AcquisitionJun 28, 2025
Closure of Trading WindowJun 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 21, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 14, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 13, 2025
Business Responsibility and Sustainability Reporting (BRSR)Jun 13, 2025
Reg. 34 (1) Annual Report.Jun 13, 2025
Notice Of 27Th Annual General Meeting To Be Held On July 5 2025Jun 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 09, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJun 09, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 03, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 31, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 26, 2025
Appointment Of Secretarial Auditor Internal Auditors & Cost Auditors Of The CompanyMay 24, 2025
The Record Date For Payment Of The Final Dividend Has Been Fixed As June 28 2025May 24, 2025
Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 24, 2025
Corporate Action-Board approves DividendMay 24, 2025
Convening Of 27Th AGM Of The Company On July 5 2025May 24, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 24, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 24, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
ICICI Prudential Multicap Fund Direct Plan-Growth
0.57%
628235
0.55%
0.57%
SBI Healthcare Opportunities Fund Direct Plan-Growth
1.27%
-191144
-0.85%
-0.85%
Motilal Oswal Small Cap Fund Direct - Growth
2.66%
102112
-0.10%
0.05%
Tata Retirement Savings Fund Moderate Plan Direct-Growth
1.67%
84912
0.42%
1.67%
Tata Retirement Savings Fund Progressive Plan Direct-Growth
1.97%
77504
0.36%
1.97%
Kotak Balanced Advantage Fund Direct - Growth
0.16%
69641
0.04%
0.13%
Tata India Pharma & Healthcare Fund Direct-Growth
2.82%
66951
0.50%
0.72%
PGIM India Small Cap Fund Direct - Growth
0.96%
-39865
-0.50%
-0.50%
Bandhan Balanced Advantage Fund Direct-Growth
0.32%
-14968
-0.13%
-0.14%
Navi Large & Midcap Fund Direct-Growth
1.37%
11500
0.41%
0.41%
Navi Flexi Cap Fund Direct - Growth
1.42%
9500
0.41%
0.40%
Helios Mid Cap Fund Direct-Growth
0.65%
7920
0.11%
-0.05%
Navi Aggressive Hybrid Fund Direct - Growth
1.38%
4500
0.40%
0.39%
Tata Nifty MidSmall Healthcare Index Fund Direct - Growth
1.29%
1647
0.02%
0.06%
SBI Nifty Smallcap 250 Index Fund Direct - Growth
0.34%
-1257
-0.06%
-0.05%
Tata Dividend Yield Fund Direct - Growth
0.02%
1209
0.02%
0.02%
Tata Retirement Savings Fund Conservative Plan Direct-Growth
0.31%
1000
0.05%
0.31%
Nippon India Nifty Smallcap 250 Index Fund Direct - Growth
0.34%
-865
-0.06%
-0.05%
JioBlackRock Nifty Smallcap 250 Index Fund Direct - Growth
0.34%
851
-0.05%
0.34%
Motilal Oswal Nifty Smallcap 250 Index Fund Direct - Growth
0.34%
-591
-0.06%
-0.05%
HDFC Nifty Smallcap 250 Index Fund Direct-Growth
0.34%
-429
-0.06%
-0.05%
Edelweiss Nifty Smallcap 250 Index Fund Direct - Growth
0.34%
373
-0.06%
-0.05%
Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct-Growth
1.29%
348
0.02%
0.05%
ICICI Prudential Nifty Smallcap 250 Index Fund Direct - Growth
0.34%
-267
-0.06%
-0.05%
Nippon India Nifty 500 Equal Weight Index Fund Direct-Growth
0.20%
247
-0.01%
-0.01%

Technical Indicators

RSI(14)
Neutral
41.78
ATR(14)
Volatile
31.12
STOCH(9,6)
Neutral
44.83
STOCH RSI(14)
Overbought
80.69
MACD(12,26)
Bullish
4.33
ADX(14)
Strong Trend
34.88
UO(9)
Bearish
43.54
ROC(12)
Downtrend And Accelerating
-0.53
WillR(14)
Neutral
-34.89

About Rainbow Childrens Medicare

Rainbow Children's Medicare Limited is a leading chain of multi-specialty pediatric, obstetrics, and gynecology hospitals in India. Originally incorporated in 1998, it operates 16 hospitals and three clinics across six cities, with a total bed capacity of 1,655. The company specializes in pediatric services, including newborn and pediatric intensive care, multi-specialty services, and quaternary care, as well as obstetrics and gynecology services. Founded by Dr. Ramesh Kancharla, Rainbow follows a full-time, exclusive doctor-led model of healthcare delivery. The company expanded its services over the years, establishing hospitals in various cities and introducing new specialties. In 2022, Rainbow completed an Initial Public Offering and its shares were listed on the National Stock Exchange of India Limited and BSE Limited. The company also offers post-graduate DNB and fellowship programs in pediatrics.
Listing Date
10 May, 2022(3 Years, 10 days)
Chairperson NameRamesh Kancharla